ID

28962

Description

Study part: Study Drug Administration Day 0. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Mots-clés

Versions (1)
  1. 18/02/2018 18/02/2018 -
Détendeur de droits

Roche

Téléchargé le

18 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Study Drug Administration Day 0 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g

Anglais

Study Drug Administration Day 0

1 Formulaires  
STUDY DRUG ADMINISTRATION (DAY 0)
Description

STUDY DRUG ADMINISTRATION (DAY 0)

Alias
UMLS CUI-1
C3469597
Subject Number:
Description

Subject Number

Type de données

text

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Description

Subject Initials

Type de données

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Visit Date:
Description

Visit Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Chosen Study Eye:
Description

Eye

Type de données

text

Alias
UMLS CUI [1]
C0015392
Was treatment (rhuFab V2 or sham procedure) administered?
Description

Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
If Yes, Record kit # administered:
Description

identification number

Type de données

text

Alias
UMLS CUI [1]
C1300638
Date Administered:
Description

Date Administered

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1533734
Time Administered:
Description

Time Administered

Type de données

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1533734
Was lidocaine injection administered?
Description

Drug Administration lidocaine

Type de données

boolean

Alias
UMLS CUI [1,1]
C3469597
UMLS CUI [1,2]
C0023660
Were preoperative antimicrobials given?
Description

preoperative antimicrobials

Type de données

boolean

Alias
UMLS CUI [1]
C2114165
Retour au début de la page

Similar models

Study Drug Administration Day 0

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
STUDY DRUG ADMINISTRATION (DAY 0)
C3469597 (UMLS CUI-1)
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Item
Chosen Study Eye:
text
C0015392 (UMLS CUI [1])
Eye
Code List
Chosen Study Eye:
CL Item
Right Eye (Right Eye)
C0229089 (UMLS CUI-1)
(Comment:en)
CL Item
Left Eye (Left Eye)
C0229090 (UMLS CUI-1)
(Comment:en)
Therapy
Item
Was treatment (rhuFab V2 or sham procedure) administered?
boolean
C0087111 (UMLS CUI [1])
identification number
Item
If Yes, Record kit # administered:
text
C1300638 (UMLS CUI [1])
Date Administered
Item
Date Administered:
date
C0011008 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
Time Administered
Item
Time Administered:
time
C0040223 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
Drug Administration lidocaine
Item
Was lidocaine injection administered?
boolean
C3469597 (UMLS CUI [1,1])
C0023660 (UMLS CUI [1,2])
preoperative antimicrobials
Item
Were preoperative antimicrobials given?
boolean
C2114165 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial